SHOUCHENG (00697) additional investment in Top Medical

SHOUCHENG (00697) issued a announcement that, recently, the fund investment managed by the affiliated company of Shoucheng Capital (a wholly-owned subsidiary of the Company) invested in Topotec Medical Technology Group Co., Ltd. (formerly known as Topotec Medical Technology Co., Ltd.). This investment is an additional investment following the investment in March 2025, which will further promote the research and development and iterative upgrade of the invested company's products, and further promote global commercial expansion. Topotec Medical is an innovative enterprise focusing on the research and production of high-end ophthalmic medical equipment, with ophthalmic imaging diagnosis and treatment equipment as its core. Relying on independently developed optical imaging, artificial intelligence, and precision manufacturing technologies, the company is committed to providing intelligent, precise, and minimally invasive one-stop ophthalmic clinical solutions for global medical institutions, and aims to become a global high-end ophthalmic equipment platform supplier. This investment will provide greater momentum for Topotec Medical in terms of working capital reserves, product iterative upgrades, and global commercial expansion, helping it achieve greater breakthroughs in technology research and actively support its overseas market expansion. In the future, the Company will continue to increase its investment layout in the Siasun Robot & Automation industry, especially in cooperation with leading enterprises in the segmented track, aiming to promote the integration and development of the medical Siasun Robot & Automation and its upstream and downstream industry chains through capital empowerment and industry synergy, assisting the high-end medical Siasun Robot & Automation industry ecosystem to reach new heights.